• CEO, Flagship Pioneering and Chairman, Moderna

  • CEO, Molecular Partners

  • Senior Reporter, ApexOnco

  • President & CEO at Bellus Health

  • Director of Visibility and External Communications, BeiGene

  • Executive Chairperson, EQRX

  • Former President, Novartis Institutes for BioMedical Research

  • Senior Editor, Endpoints

  • President & CEO, MiNK Therapeutics

  • Editor, Biotech Strategy Blog

  • Co-CEO and Co-Founder, Amylyx Pharmaceuticals

  • CEO, Corbus Pharmaceuticals

  • Executive Editor and Head of Daily Global Intelligence, BioCentury

  • Founder & Managing Director Pharmagellan; Tufts Professor and Author

  • Reporter, STAT

  • CEO, Codexis

  • Chief Innovation and Strategy Officer, PureTech Health; Inventor of KarXT Platform & Founding CEO, Karuna Therapeutics

  • CEO, Beam Therapeutics

  • Senior pharmaceuticals analyst for Bloomberg Intelligence and director of research for EMEA.

  • Senior Writer, STAT

  • Editor in Chief, BioCentury

  • National Biotech Reporter, STAT

  • Chief Executive Officer, Arrakis Therapeutics

  • CEO, Roivant

  • Chief Innovation Officer, Centessa

  • Director of the Medical Oncology Service, National Cancer Institute

  • SVP, Remix Therapeutics

  • Chief Investment Officer, Metagenomi

  • CEO, Nkarta

  • CMO, Arcellx

  • CEO, Immunocore

  • Pharma Columnist, Bloomberg Opinion

  • CEO, DICE Therapeutics

  • Associate Professor of Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School; Founder, Foghorn Therapeutics

  • Portfolio manager in the equity division at Fidelity Investments

  • CEO, Nimbus Therapeutics

  • Co-CEO and Co-Founder, Amylyx Pharmaceuticals

  • Executive Editor, BioCentury

  • Managing Partner, RA Capital Management

  • Co-founder, Chief Executive Officer and member of Board of Directors, BridgeBio

  • Partner in New York Office of Bessemer Venture Partners

  • Professor in Cancer Gene Therapy, University of Pennsylvania

  • President & CEO, Valneva

  • Director in Chemical Biology Therapeutics, Novartis Institutes for BioMedical Research (NIBR)

  • Former Executive Vice President of Pharmaceuticals, R&D, Johnson & Johnson

  • Former CEO of Alnylam

  • Founder and COO, Inventor of KarXT Platform, Karuna Therapeutics

  • CEO, EQRX

  • Co-founder and Managing Director, ARCH Venture Partners

  • Managing director, SVB's Healthcare practice

  • CEO, bluebird bio

  • Founder Semma (acquired by Vertex Pharmaceuticals)

  • Researcher, UCSF Neurologic Oncology

  • Founder and CEO, Perlara PBC; Co-Founder and CEO, Maggie's Pearl

  • Journalist, ApexOnco

  • President of Research & Development, Takeda

  • CEO, Nuvalent

  • Senior Manager Director, Evercore ISI

  • Senior Editor for Biomedicine, MIT Technology Review

  • CEO, President and CSO, Aleta Biotherapeutics

  • EVP, Strategy, Nucleate

  • Life Sciences Portfolio Manager

  • Biotech Analyst, Cantor

  • Biopharma writer, Nature Biotechnology and In Vivo

  • CEO, Kite Pharma

  • Chief Advocacy Officer, BIO

  • CEO, Immatics

  • Senior Research Analyst, Baird

  • President and CEO, Trillium Therapeutics

  • Founder, Timmerman Report

  • CEO Morphic Therapeutic

  • Partner and a Founding Member of the Healthcare Practice, Centerview Partners

  • Scientific Director, Innovative Genomics Institute; Professor, MCB Department, UC Berkeley; Scientific co-founder, Tune Therapeutics

  • Washington Editor, BioCentury

  • Managing Editor, Enterprise, MarketWatch and author of For Blood and Money: Billionaires, Biotech, and the Quest for a Blockbuster Drug

  • CEO, Portage Bio

  • Senior Biotechnology Analyst, TD Cowen